Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial-Reference-Cited by-同舟云学术

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial

Published:2022-05-02 Issue:1 Volume:100 Page:72-82
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Ono Masafumi¹²^ORCID,Onuma Yoshinobu²,Kawashima Hideyuki¹²^ORCID,Hara Hironori¹²,Gao Chao³⁴^ORCID,Wang Rutao³⁴,O'Leary Neil²,Benit Edouard⁵⁶,Janssens Luc⁷,Ferrario Maurizio⁸,Żurakowski Aleksander⁹,Dominici Marcello¹⁰,Huber Kurt¹¹,Buszman Paweł¹²,Garg Scot¹³,Wykrzykowska Joanna J.¹¹⁴,Piek Jan J.¹,Jüni Peter¹⁵,Hamm Christian¹⁶,Windecker Stephan¹⁷,Vranckx Pascal¹⁸,Deliargyris Efthymios N.¹⁹,Bhatt Deepak L.²⁰,Storey Robert F.²¹,Valgimigli Marco²²^ORCID,Serruys Patrick W.²²³^ORCID,

Affiliation:

1. Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Heart Center University of Amsterdam Amsterdam The Netherlands

2. Interventional Medicine and Innovation National University of Ireland Galway (NUIG) Galway Ireland

3. Department of Cardiology Radboud University Medical Center Nijmegen The Netherlands

4. Department of Cardiology Xijing Hospital Xi'an China

5. Department of Cardiology and Critical Care Medicine Hartcentrum Hasselt, Jessa Ziekenhuis Hasselt Belgium

6. Faculty of Medicine and Life Sciences University of Hasselt Hasselt Belgium

7. Imelda Ziekenhuis Bonheiden Belgium

8. Policlinico San Matteo Pavia Italy

9. Frycz‐Modrzewski Academy—Cracow Cracow Poland

10. Azienda Ospedaliera S. Maria Terni Italy

11. Wilhelminenspital Vienna Austria

12. Department of Epidemiology Silesian Medical School Katowice Poland

13. Department of Cardiology Royal Blackburn Hospital Blackburn UK

14. University Medical Center Groningen Groningen The Netherlands

15. Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital University of Toronto Toronto Ontario Canada

16. University of Giessen and Kerckhoff Heartand Thorax Center University of Giessen Bad Nauheim Germany

17. Department of Cardiology, Inselspital University of Bern Bern Switzerland

18. Jessa Ziekenhuis, Faculty of Medicine and Life Sciences at the Hasselt University Hasselt Belgium

19. Cytosorbents Corporation Monmouth Junction New Jersey USA

20. Harvard Medical School Brigham and Women's Hospital Heart & Vascular Center Boston Massachusetts USA

21. Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK

22. Cardiocentro Ticino Institute Università della Svizzera Italiana (USI) Lugano Switzerland

23. NHLI, Imperial College London London UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30217

Reference27 articles.

1. 2018 ESC/EACTS Guidelines on myocardial revascularization

2. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

3. Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome

4. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study

5. Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effects of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention in High-Risk Subgroups;Circulation Journal;2024-08-06

2. Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis;BMC Cardiovascular Disorders;2024-07-17

3. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?;Expert Opinion on Drug Metabolism & Toxicology;2024-07-15

4. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view;World Journal of Cardiology;2023-08-26

5. Emerging Clinical Problem of Resistance to Antiplatelet Therapy in Primary Prevention and Treatment of Cardiovascular Events in People Living with HIV: Conundrum despite Effective cART;Infectious Diseases;2023-08-26